At Liferna, the phrase “patient-first” is not a marketing line — it is the standard against which every decision is measured. From how we design trials to how we partner with advocacy organizations, the lived experience of patients is at the center of our work.
Designing trials around patients, not the other way around
Recurrent cervical cancer, idiopathic pulmonary fibrosis, systemic sclerosis — these are diseases that reshape lives. Our clinical teams work closely with patients and clinicians to understand what truly matters: time, function, independence, and quality of life. These insights inform endpoints, study design, and how we communicate progress.
Listening, then acting
Over the past year, Liferna has expanded its Patient & Advocacy Council to include voices from oncology, pulmonary, and rheumatologic disease communities. The council meets regularly with our development teams to provide direct input on:
- Trial accessibility and site selection
- Patient-reported outcome measures
- Communication of clinical milestones and safety information
- Long-term access and affordability planning
“The patients and families we work with are not stakeholders to be informed — they are partners in the work itself. Their input has made our programs stronger and more humane.”
What’s next
Liferna will be sharing more patient stories and advocacy initiatives throughout 2026, including spotlights from our partner organizations and expanded resources on the Patients & Advocacy section of our website.